HUMMINGBIRD BIOSCIENCE
Hummingbird Bioscience uses systems biology to develop insights into disease biology and applies computationally guided platforms to discover and engineer breakthrough biotherapeutics. The company is pursuing a broad pipeline of first drug candidates across multiple challenging targets with strong biological validation and disease association, including lead assets: HMBD-001, an anti-HER3 antibody, and HMBD-002, an anti-VISTA antibody, for the treatment of cancer. Hummingbird has established strategic collaborations with Cancer Research UK and Amgen, and has been awarded a product development grant from the Cancer Prevention and Research Institute of Texas.
HUMMINGBIRD BIOSCIENCE
Industry:
Biotechnology Health Care Therapeutics
Founded:
2014-01-01
Address:
Woodlands, North Region, Singapore
Country:
Singapore
Website Url:
http://www.hummingbirdbioscience.com
Total Employee:
101+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
150 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics Domain Not Resolving
Current Advisors List
Current Employees Featured
Founder
Investors List
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Series C - Hummingbird Bioscience
Novo Holdings
Novo Holdings investment in Series C - Hummingbird Bioscience
Octagon Capital Advisors
Octagon Capital Advisors investment in Series C - Hummingbird Bioscience
Pureos Bioventures
Pureos Bioventures investment in Series C - Hummingbird Bioscience
EDBI
EDBI investment in Series C - Hummingbird Bioscience
Amgen Ventures
Amgen Ventures investment in Series C - Hummingbird Bioscience
Mirae Asset Venture Investment
Mirae Asset Venture Investment investment in Series C - Hummingbird Bioscience
Droia Ventures
Droia Ventures investment in Series C - Hummingbird Bioscience
Polaris Partners
Polaris Partners investment in Series C - Hummingbird Bioscience
Heritas Capital
Heritas Capital investment in Series C - Hummingbird Bioscience
Key Employee Changes
Date | New article |
---|---|
2021-09-01 | Hummingbird Bioscience Strengthens Leadership Team with Appointment of Josh House as Chief Financial Officer |
Official Site Inspections
http://www.hummingbirdbioscience.com Semrush global rank: 4.05 M Semrush visits lastest month: 3.02 K
- Host name: 51.225.174.34.bc.googleusercontent.com
- IP address: 34.174.225.51
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago